Skip to main content

NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.

Publication ,  Journal Article
Gradishar, WJ; Moran, MS; Abraham, J; Abramson, V; Aft, R; Agnese, D; Allison, KH; Anderson, B; Burstein, HJ; Chew, H; Dang, C; Elias, AD ...
Published in: J Natl Compr Canc Netw
June 2023

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number of treatment options, if one option fails, there is usually another line of therapy available, providing meaningful improvements in survival. This NCCN Guidelines Insights report focuses on recent updates specific to systemic therapy recommendations for patients with stage IV (M1) disease.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

June 2023

Volume

21

Issue

6

Start / End Page

594 / 608

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Female
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gradishar, W. J., Moran, M. S., Abraham, J., Abramson, V., Aft, R., Agnese, D., … Kumar, R. (2023). NCCN Guidelines® Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw, 21(6), 594–608. https://doi.org/10.6004/jnccn.2023.0031
Gradishar, William J., Meena S. Moran, Jame Abraham, Vandana Abramson, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, et al. “NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.J Natl Compr Canc Netw 21, no. 6 (June 2023): 594–608. https://doi.org/10.6004/jnccn.2023.0031.
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw. 2023 Jun;21(6):594–608.
Gradishar, William J., et al. “NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.J Natl Compr Canc Netw, vol. 21, no. 6, June 2023, pp. 594–608. Pubmed, doi:10.6004/jnccn.2023.0031.
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, Mortimer J, Patel SA, Pierce LJ, Rosenberger LH, Rugo HS, Schneider B, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Young JS, Yeung K, Dwyer MA, Kumar R. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw. 2023 Jun;21(6):594–608.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

June 2023

Volume

21

Issue

6

Start / End Page

594 / 608

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Female
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis